Adverse Drug Event
73
10
10
40
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.4%
1 terminated out of 73 trials
97.6%
+11.1% vs benchmark
16%
12 trials in Phase 3/4
15%
6 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (73)
Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)
MEOP - Multidimensional Evaluations in Oncological Psychiatry
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients
A Study of GC101 TIL in Advanced Melanoma (BZ)
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase
Melatonin for Prevention of Kidney Injury
A Phase I Study of GC101 TIL in Advanced Solid Tumors
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery
Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
NUDGE-EHR Replication Trial at Mass General Brigham
Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults
Safety of Pediatric COVID-19 Vaccination
Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing
Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Simultaneous RZV and aIIV4 Vaccination
Collaborative Nurse-pharmacist Counseling for Self-administered Biologics
Over-the-counter (OTC) Labels for Older Adults